RANDOMIZED PHASE-III TRIAL OF CHEMO-IMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-III, OPTIMAL DISEASE OVARIAN-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

被引：12

作者：

ALBERTS, DS

MASONLIDDIL, N

OTOOLE, RV

ABBOTT, TM

KRONMAL, R

HILGERS, RD

SURWIT, EA

EYRE, HJ

BAKER, LH

机构：

[1] ARIZONA CANC CTR,TUCSON,AZ 85724

[2] OHIO STATE UNIV,CTR HLTH,COLUMBUS,OH 43210

[3] SW ONCOL GRP,CTR BIOSTAT,SEATTLE,WA 98104

[4] UNIV NEW MEXICO,ALBUQUERQUE,NM 87131

[5] WAYNE STATE UNIV,MED CTR,DETROIT,MI 48201

来源：

GYNECOLOGIC ONCOLOGY | 1989年 / 32卷 / 01期

关键词：

D O I：

10.1016/0090-8258(89)90842-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：16 / 21

页数：6

共 21 条

[11] ANALYSIS OF DOSE INTENSITY FOR ADJUVANT CHEMOTHERAPY TRIALS IN STAGE-II BREAST-CANCER [J].

HRYNIUK, W ;

LEVINE, MN .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) :1162-1170

[12] DOSE INTENSITY ANALYSIS OF CHEMOTHERAPY REGIMENS IN OVARIAN-CARCINOMA [J].

LEVIN, L ;

HRYNIUK, WM .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) :756-767

[13]

OMURA G, 1986, CANCER, V57, P1725, DOI 10.1002/1097-0142(19860501)57:9<1725::AID-CNCR2820570903>3.0.CO

[14]

2-J

[15] HIGH-DOSE CISPLATIN IN HYPERTONIC SALINE [J].

OZOLS, RF ;

CORDEN, BJ ;

JACOB, J ;

WESLEY, MN ;

OSTCHEGA, Y ;

YOUNG, RC .

ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) :19-24

[16]

PARKER LM, 1980, CANCER, V46, P669, DOI 10.1002/1097-0142(19800815)46:4<669::AID-CNCR2820460407>3.0.CO

[17]

2-P

[18] THE POTENTIAL FOR OPTIMAL (LESS-THAN-OR-EQUAL-TO-2 CM) CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN-CARCINOMA AT A TERTIARY MEDICAL-CENTER - A PROSPECTIVE-STUDY [J].

PIVER, MS ;

BAKER, T .

GYNECOLOGIC ONCOLOGY, 1986, 24 (01) :1-8

[19]

SILVERBERG E, 1986, CA-CANCER J CLIN, V36, P9

[20] LONG-TERM SURVIVAL AFTER CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CARCINOMA [J].

WHARTON, JT ;

EDWARDS, CL ;

RUTLEDGE, FN .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 148 (07) :997-1005

← 1 2 3 →